TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.

Bodewes, Iris L A; Huijser, Erika; van Helden-Meeuwsen, Cornelia G; Tas, Liselotte; Huizinga, Ruth; Dalm, Virgil A S H; van Hagen, P Martin; Groot, Noortje; Kamphuis, Sylvia; van Daele, Paul L A; Versnel, Marjan A.
J Autoimmun; 91: 97-102, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29673738